Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-29 | James F. Young, Ph.D., Age 57, Chairman of the Board since April 2011. Received $33,350 in fees and $34,892 in option awards for total compensation of $68,242 in 2010. |
| 2012-04-30 | Dr. Young received cash retainers of $42,500 for his service as Chairman of the Board of Directors, from April 19, 2011, and outside director, $6,500 for his service as Chairman of the Compensation Committee, and $3,500 for his participation on the Nominating and Corporate Governance Committee. He received $11,000 for his attendance at Board and Committee meetings. Total compensation was $390,800. |
| 2013-04-30 | James F. Young, Ph.D. 60 Former President, Research and Development, MedImmune, Inc. Dr. Young has been Chairman of the Board since April 2011 and a Director of Novavax since April 2010. He has over 30 years of experience in the fields of molecular genetics, microbiology, immunology, and pharmaceutical development. Dr. Young brings extensive scientific background and experiences, particularly in the areas of vaccine research and development. |
| 2015-04-30 | James F. Young, Ph.D. 62 2010 Former President, Research and Development, MedImmune, Inc. ... Dr. Young has been Chairman of the Board since April 2011 and a Director of Novavax, Inc. since April 2010. ... James Young, Ph.D. Fees Earned or Paid in Cash ($) 92,500 Option Awards ($) 298,538 Total ($) 391,038 |
| 2016-04-20 | James F. Young, Ph.D. Age: 63 Former President, Research and Development, at MedImmune, Inc. Chairman of the Board since April 2011 Board Committees: Chair of Compensation Committee, Member of Nominating and Corporate Governance Committee Summary Director Compensation Table: James F. Young, Ph.D. - Total compensation $734,500 |
| 2017-04-28 | James F. Young, Ph.D. Age: 64 Year First Elected Director: 2010 Chairman of the Board and Chief Executive Officer of Targeted Microwave Solutions, Inc. since 2016. Dr. Young has been Chairman of the Board of Novavax, Inc. since April 2011 and a Director since April 2010. |
| 2018-04-30 | James F. Young, Ph.D. Age: 65 Year First Elected Director: 2010... Chairman of the Board and Chief Executive Officer of Targeted Microwave Solutions, Inc. since 2016... Board Committees: Compensation Committee Chair, Nominating and Corporate Governance Committee Member... Summary Director Compensation Table: James Young, Ph.D. Total: $533,780. |
| 2019-04-01 | James F. Young, Ph.D. is listed as a director in the Security Ownership table. No age, committees, or compensation details are provided. |
| 2019-05-16 | James F. Young, Ph.D. Age: 66 Former Chairman of the Board and Chief Executive Officer of Targeted Microwave Solutions, Inc. from 2016 to 2018. Former President, Research and Development, at MedImmune, Inc. Dr. Young has been Chairman of the Board of Novavax, Inc. since April 2011 and a Director since April 2010. Board Committees James F. Young, Ph.D. Compensation Committee Chair Nominating and Corporate Governance Committee Member Summary Director Compensation Table James Young, Ph.D. Fees Earned or Paid in Cash: $94,375 Option Awards: $377,340 Total: $471,715 |
| 2020-05-13 | James F. Young, Ph.D. Age: 67 Chairman of the Board Compensation Committee Chair Nominating and Corporate Governance Committee Member 2019 Compensation: $223,741 |
| 2021-05-03 | James F. Young, Ph.D. Former Chairman of the Board and Chief Executive Officer, Targeted Microwave Solutions, Inc. Age 68 Director Since 2010 Chairman of the Board Since 2011 Committees: Nominating and Corporate Governance, Research and Development Compensation: $4,387,708 total compensation in 2020. |
| 2022-05-02 | James F. Young, Ph.D. Former Chairman of the Board and Chief Executive Officer, Targeted Microwave Solutions, Inc. Age 69 Chairman of the Board Since 2011 Committees: Nominating and Corporate Governance, Research and Development Compensation: $761,081 |
| 2023-04-28 | James F. Young, Ph.D. Age 70 INDEPENDENT DIRECTOR SINCE 2010 CHAIRMAN OF THE BOARD SINCE 2011 COMMITTEES Nominating & Corporate Governance Research & Development Fees Earned or Paid in Cash ($): 116,500 Option Awards ($): 258,201 Stock Awards ($): 186,852 Total ($): 561,553 |
| 2024-04-29 | James F. Young, Ph.D. Chairman of the Board since 2011 Independent Director since 2010 Committees: Nominating & Corporate Governance, Research & Development Director Compensation Table: Total compensation $222,533. |
Data sourced from SEC filings. Last updated: 2026-02-03